参考文献/References:
[1] Ferrari R, Bertini M, Blomstrom-Lundqvist C,et al. An update on atrial fibrillation in 2014: from pathophysiology to treatment[J].Int J Cardiol, 2016,203:22-29. DOI: 10.1016/j.ijcard.2015.10.089.
[2] Harada M, Van Wagoner DR, Nattel S. Role of inflammation in atrial fibrillation pathophysiology and management[J].Circ J,2015,79(3):495-502. DOI: 10.1253/circj.CJ-15-0138.
[3] Hu YF, Chen YJ, Lin YJ,et al. Inflammation and the pathogenesis of atrial fibrillation[J].Nat Rev Cardiol,2015,12(4):230-243. DOI: 10.1038/nrcardio.2015.2.
[4] Watson T, Kakar P, Lip GY. Cardioversion for atrial fibrillation: does inflammation matter [J].Am J Cardiol,2007,99(11):1617-1618.
[5] Liu T, Li G, Li L,et al. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis[J].J Am Coll Cardiol,2007,49(15):1642-1648.
[6] Korantzopoulos P, Kolettis TM, Kountouris E,et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation[J]. Int J Cardiol,2005,102(2):321-326.
[7] Korantzopoulos P, Kolettis TM, Galaris D,et al. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation[J].Int J Cardiol,2007,115(2):135-143.
[8] Bruins P, te Velthuis H, Yazdanbakhsh AP,et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia[J].Circulation,1997,96(10):3542-3548.
[9] Liu T, Li L, Korantzopoulos P,et al. Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation[J].Am J Cardiol,2008,101(12):1749-1752. DOI: 10.1016/j.amjcard.2008.02.066.
[10] Dudley SC Jr, Hoch NE, McCann LA,et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases[J]. Circulation,2005,112(9):1266-1273.
[11] Baker JF, Krishnan E, Chen L,et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us [J].Am J Med,2005,118(8):816-826.
[12] Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk[J].N Engl J Med,2008,359(17):1811-1821. DOI: 10.1056/NEJMra0800885.
[13] Krishnan E, Svendsen K, Neaton JD,et al. Long-term cardiovascular mortality among middle-aged men with gout[J]. Arch Intern Med,2008,168(10):1104-1110. DOI: 10.1001/archinte.168.10.1104.
[14] Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease[J].Circulation,2007,116(8):894-900.
[15] Borghi C, Verardi FM, Pareo I,et al. Hyperuricemia and cardiovascular disease risk[J].Expert Rev Cardiovasc Ther,2014,12(10):1219-1225. DOI: 10.1586/14779072.2014.957675.
[16] 马进才,邵清淼,刘彤. 高尿酸血症与心房颤动相关性的研究现状 [J]. 中国心血管杂志, 2014, 19(4):314-316. DOI:10.3969/j.issn.1007-5410.2014.04.29.
[17] Suzuki S, Sagara K, Otsuka T,et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence[J].Circ J,2012,76(3):607-611.
[18] Tamariz L, Agarwal S, Soliman EZ,et al. Association of serum uric acid with incident atrial fibrillation(from the Atherosclerosis Risk in Communities [ARIC] study)[J].Am J Cardiol,2011,108(9):1272-1276. DOI: 10.1016/j.amjcard.2011.06.043.
[19] Chao TF, Hung CL, Chen SJ,et al. The association between hyperuricemia, left atrial size and new-onset atrial fibrillation[J].Int J Cardiol,2013,168(4):4027-4032. DOI: 10.1016/j.ijcard.2013.06.067.
[20] Nyrnes A, Toft I, Njølstad I,et al. Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study[J].Europace,2014,16(3):320-326. DOI: 10.1093/europace/eut260.
[21] Liu T, Zhang X, Korantzopoulos P,et al. Uric acid levels and atrial fibrillation in hypertensive patients[J].Intern Med,2011,50(8):799-803.
[22] Chuang SY, Wu CC, Hsu PF, et al. Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan[J]. Nutr Metab Cardiovasc Dis,2014,24(9):1020-1026. DOI: 10.1016/j.numecd.2014.03.012.
[23] Valbusa F, Bertolini L, Bonapace S,et al. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus[J].Am J Cardiol,2013,112(4):499-504. DOI: 10.1016/j.amjcard.2013.04.012.
[24] Memetoglu ME, Kehlibar T, Y1lmaz M,et al. Serum uric acid level predicts new-onset atrial fibrillation after coronary artery bypass graft operation[J].Eur Rev Med Pharmacol Sci,2015,19(5):784-789.
[25] Tamariz L, Hernandez F, Bush A,et al. Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis[J].Heart Rhythm,2014,11(7):1102-1108.DOI: 10.1016/j.hrthm.2014.04.003.
[26] Canpolat U, Aytemir K, Yorgun H, et al. Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation[J].Europace,2014,16(12):1731-1737. DOI: 10.1093/europace/euu198.
[27] Zhao J, Liu T, Korantzopoulos P, et al. Association between serum uric acid and atrial fibrillation recurrence following catheter ablation: a meta-analysis[J].Int J Cardiol,2016,204:103-105. DOI: 10.1016/j.ijcard.2015.11.167.
[28] Corry DB, Eslami P, Yamamoto K,et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system[J].J Hypertens,2008,26(2):269-275. DOI: 10.1097/HJH.0b013e3282f240bf.
[29] Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells[J].J Am Soc Nephrol,2005,16(12):3553-3562.
[30] Perlstein TS, Gumieniak O, Hopkins PN,et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans[J]. Kidney Int,2004,66(4):1465-1470.
相似文献/References:
[1]黄江燕,董力,邹贵勉,等.广西城市社区居民高尿酸血症流行病学调查[J].国际内分泌代谢杂志,2014,(01):5.[doi:10.3760/cma.j.issn.1673-4157.2014.01.002]
Huang Jiangyan*,Dong Li,Zou Guimian,et al.Epidemiological survey of hyperuricemia in the Guangxi urban community residents[J].International Journal of Endocrinology and Metabolism,2014,(04):5.[doi:10.3760/cma.j.issn.1673-4157.2014.01.002]
[2]曹雯,郑仁东,曹琳,等.男性2型糖尿病患者血尿酸与性激素
相关性研究[J].国际内分泌代谢杂志,2016,36(01):28.[doi:10.3760/cma.j.issn.1673-4157.2016.01.007]
Cao Wen,Zheng Rendong,Cao Lin,et al.Correlation between blood uric acid and sex hormones in male patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(04):28.[doi:10.3760/cma.j.issn.1673-4157.2016.01.007]
[3]王靖宇,常宝成.高尿酸血症/痛风流行病学特点及危险因素[J].国际内分泌代谢杂志,2016,36(02):78.[doi:10.3760/cma.j.issn.1673-4157.2016.02.002]
Wang Jingyu,Chang Baocheng..Epidemiological characteristics and risk factors of hyperuricemia/gout[J].International Journal of Endocrinology and Metabolism,2016,36(04):78.[doi:10.3760/cma.j.issn.1673-4157.2016.02.002]
[4]聂秀玲,李明珍,孙丽荣.高尿酸血症与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2016,36(02):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
Nie Xiuling,Li Mingzhen,Sun Lirong..Hyperuricemia and non-alcoholic fatty liver[J].International Journal of Endocrinology and Metabolism,2016,36(04):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
[5]李明珍,聂秀玲,孙丽荣.高尿酸血症与糖代谢异常的关系[J].国际内分泌代谢杂志,2016,36(04):217.[doi:10.3760/cma.j.issn.1673-4157.2016.04.01]
Li Mingzhen,Nie Xiuling,Sun Lirong.Relationship between hyperuricemia and abnormalities of glucose metabolism[J].International Journal of Endocrinology and Metabolism,2016,36(04):217.[doi:10.3760/cma.j.issn.1673-4157.2016.04.01]
[6]刘华英,顾丹阳,邵加庆.高尿酸血症与内皮功能障碍[J].国际内分泌代谢杂志,2016,36(06):412.[doi:10.3760/cma.j.issn.1673-4157.2016.06.14]
Liu Huaying,Gu Danyang,Shao Jiaqing..Hyperuricemia and endothelial dysfunction[J].International Journal of Endocrinology and Metabolism,2016,36(04):412.[doi:10.3760/cma.j.issn.1673-4157.2016.06.14]
[7]曹雯,孙洪平,褚晓秋,等.生活方式干预与高尿酸血症[J].国际内分泌代谢杂志,2017,37(03):172.[doi:10.3760/cma.j.issn.1673-4157.2017.03.007]
Cao Wen,Sun Hongping,Chu Xiaoqiu,et al.Lifestyle intervention and hyperuricemia[J].International Journal of Endocrinology and Metabolism,2017,37(04):172.[doi:10.3760/cma.j.issn.1673-4157.2017.03.007]
[8]聂秀玲.长期果糖摄入与代谢综合征[J].国际内分泌代谢杂志,2018,38(05):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
Nie Xiuling.Chronic fructose intake and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(04):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
[9]朱婧 蒋晓红 项守奎 许晨 华飞.1型糖尿病患者尿酸水平与血脂异常的
相关性研究[J].国际内分泌代谢杂志,2020,40(01):16.[doi:10.3760/cma.j.issn.1673-4157.2020.01.004]
Zhu Jing,Jiang Xiaohong,Xiang Shoukui,et al.Correlation between uric acid level and dyslipidemia in patients with type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2020,40(04):16.[doi:10.3760/cma.j.issn.1673-4157.2020.01.004]
[10]冯露文,成志锋.尿酸转运蛋白及其相互作用蛋白在尿酸代谢中的作用研究进展[J].国际内分泌代谢杂志,2021,41(03):220.[doi:10.3760/cma.j.cn121383-20200608-06017]
Feng Luwen,Cheng Zhifeng..Research progress on the role of uric transporters and its protein interaction in uric acid metabolism[J].International Journal of Endocrinology and Metabolism,2021,41(04):220.[doi:10.3760/cma.j.cn121383-20200608-06017]